Investor has been focused on protecting inventions in European Patent Office(EPO) with 19 publications in Q2 2024

The European Patent Office(EPO) Patent Office dominates the patent filings and grants with nearly 33% filings and 29% grants. The European Patent Office(EPO), United States(US), World Intellectual Property Organization(WIPO), and Australia(AU) patent Office are among the top ten patent offices where Investor is filings its patents. Among the top granted patent authorities, Investor has 43% of its grants in United States(US), 29% in European Patent Office(EPO) and 21% in Spain(ES).

Aatru Medical and Smith & Nephew could be the strongest competitors for Investor

Investor stands in second position with respect to its patent publications among its competitors.

Adhesive bandages and plasters related patents lead Investor portfolio followed by first aid and wound care, and wound care management

Investor has highest number of patents in adhesive bandages and plasters followed by first aid and wound care, wound care management, negative pressure wound therapy (npwt), and nephrology and urology devices. For adhesive bandages and plasters, nearly 32% of patents were filed and 22% of patents were granted in Q2 2024.

For comprehensive analysis of Investor's filings and grants, buy the databook here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

Be better informed